INVO Bioscience Inc (NASDAQ: INVO) kicked off on November 20, 2023, at the price of $1.72, down -4.97% from the previous trading day. During the day, the shares moved up to $1.91 and dropped to $1.71 before settling in for the closing price of $1.81. Over the past 52 weeks, INVO has traded in a range of $0.50-$24.79.
Annual sales at Healthcare sector company grew by 93.11% over the past five years. While this was happening, its average annual earnings per share was recorded 66.28%. With a float of $2.45 million, this company’s outstanding shares have now reached $2.47 million.
Let’s look at the performance matrix of the company that is accounted for 15 employees. In terms of profitability, gross margin is +27.85, operating margin of -1292.45, and the pretax margin is -1324.46.
INVO Bioscience Inc (INVO) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of INVO Bioscience Inc is 0.94%, while institutional ownership is 12.88%.
INVO Bioscience Inc (INVO) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/30/2022, the organization reported -$0.23 earnings per share (EPS), lower than consensus estimate (set at -$0.19) by -$0.04. This company achieved a net margin of -1324.81 while generating a return on equity of -343.99. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 66.28% per share during the next fiscal year.
INVO Bioscience Inc (NASDAQ: INVO) Trading Performance Indicators
Take a look at INVO Bioscience Inc’s (INVO) current performance indicators. Last quarter, stock had a quick ratio of 0.31. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.21.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -12.41, a number that is poised to hit -0.87 in the next quarter and is forecasted to reach -0.29 in one year’s time.
Technical Analysis of INVO Bioscience Inc (INVO)
INVO Bioscience Inc (NASDAQ: INVO) saw its 5-day average volume 5.83 million, a positive change from its year-to-date volume of 1.16 million. As of the previous 9 days, the stock’s Stochastic %D was 64.31%. Additionally, its Average True Range was 0.38.
During the past 100 days, INVO Bioscience Inc’s (INVO) raw stochastic average was set at 18.21%, which indicates a significant decrease from 59.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 355.56% in the past 14 days, which was higher than the 294.23% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0837, while its 200-day Moving Average is $5.4209. Nevertheless, the first resistance level for the watch stands at $1.8500 in the near term. At $1.9800, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.0500. If the price goes on to break the first support level at $1.6500, it is likely to go to the next support level at $1.5800. Assuming the price breaks the second support level, the third support level stands at $1.4500.
INVO Bioscience Inc (NASDAQ: INVO) Key Stats
The company with the Market Capitalisation of 4.25 million has total of 2,450K Shares Outstanding. Its annual sales at the moment are 820 K in contrast with the sum of -10,890 K annual income. Company’s last quarter sales were recorded 320 K and last quarter income was -2,240 K.